Cargando…
Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice
SARS-CoV-2 infection is a global public health threat. Vaccines are considered amongst the most important tools to control the SARS-CoV-2 pandemic. As expected, deaths from SARS-CoV-2 infection have dropped dramatically with widespread vaccination. However, there are concerns over the duration of va...
Autores principales: | Lu, Mingqing, Liu, Kunpeng, Peng, Yun, Ding, Zhe, Li, Yingwen, Tendu, Alexander, Hu, Xue, Gao, Ge, Guo, Weiwei, Liu, Hang, Rao, Juhong, Zhao, Jiaxuan, Chen, Miaoyu, Yuan, Zhiming, Wong, Gary, Shan, Chao, Yao, Yanfeng, Lan, Jiaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wuhan Institute of Virology, Chinese Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156438/ https://www.ncbi.nlm.nih.gov/pubmed/35659605 http://dx.doi.org/10.1016/j.virs.2022.05.006 |
Ejemplares similares
-
Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection
por: Lu, Mingqing, et al.
Publicado: (2023) -
Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2023) -
Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
por: Collignon, Catherine, et al.
Publicado: (2020) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013) -
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19
por: Xu, Kun, et al.
Publicado: (2021)